Find out what drove John McKearn, Ph.D. a CEO at Wugen, out of the lab at Pfizer and on to his quest to develop off-the-shelf cell therapies for T-Cell leukemias and lymphomas, Acute Myeloid Leukemia, and Multiple Myeloma.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Business Of Biotech","authorlink":""},"src":"https:\/\/www.buzzsprout.com\/1011661\/6070663-off-the-shelf-car-t-cell-therapy.mp3?blob_id=25151638","thumb":{"src":"https:\/\/storage.buzzsprout.com\/35u0bccu9j9xpr9zrrjias54otax?.jpg"},"title":"Off-The-Shelf CAR T-Cell Therapy?","link":"javascript:;","id":"item-888910"}]
